|
Status |
Public on Jan 23, 2015 |
Title |
253949410878-3 |
Sample type |
RNA |
|
|
Source name |
SKOV3ipL, shNT
|
Organism |
Homo sapiens |
Characteristics |
cell line: SKOV3ipL cell type: ovarian carcinoma cell line shRNA: negative control (shNT) amount in (µg): 0.2 rin number: 10
|
Treatment protocol |
Stable knock down of CD63 was performed in SKOV3ipL ovarian carcinoma cell line using 2 shRNAs lentiviral constructs (sh49 and sh51), and as a negative control, a shNT construct. Parental cells, control shNT and the 2 shCD63 cell lines were seeded 24 hours prior to RNA isolation on a 10 cm dish.
|
Extracted molecule |
total RNA |
Extraction protocol |
Trizol
|
Label |
Cy3
|
Label protocol |
Agilent: Low RNA Input QuickAmp.
|
|
|
Hybridization protocol |
Agilent: 200.0 ng at 65 degree_C during 17 hours.
|
Scan protocol |
Arrays were scanned using the Agilent SureScan High Resolution Scanner.
|
Description |
SKOV3ipL_shNT_1
|
Data processing |
Feature extraction data processing. Quantile normalization and paired differential analysis in R / Bioconductor.
|
|
|
Submission date |
Oct 01, 2014 |
Last update date |
Jan 24, 2015 |
Contact name |
Kevin Lebrigand |
Organization name |
IPMC/CNRS
|
Lab |
Functional Genomics Platform of Nice-Sophia-Antipolis, France.
|
Street address |
660 route des lucioles
|
City |
Valbonne - Sophia-Antipolis |
ZIP/Postal code |
06560 |
Country |
France |
|
|
Platform ID |
GPL17077 |
Series (1) |
GSE61957 |
Tetraspanin CD63 acts as a pro-metastatic factor via β-catenin stabilization |
|